Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia

NCT00976248 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
33
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dana-Farber Cancer Institute

Collaborators